Detalhe da pesquisa
1.
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
Nature
; 569(7756): 428-432, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043740
2.
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer.
Int J Cancer
; 145(7): 1991-2001, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30848481
3.
Cytokines in clinical cancer immunotherapy.
Br J Cancer
; 120(1): 6-15, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413827
4.
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
J Pathol
; 245(4): 421-432, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756233
5.
Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis.
Clin Chem Lab Med
; 57(10): 1539-1545, 2019 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30990781
6.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet
; 389(10064): 67-76, 2017 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939400
7.
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Lancet Oncol
; 18(5): 672-681a, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389316
8.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26952546
9.
Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.
Clin Chem
; 61(1): 297-304, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25411185
10.
Role of [¹8F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
Eur J Nucl Med Mol Imaging
; 41(11): 2058-65, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990403
11.
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.
Clin Transl Oncol
; 26(3): 732-738, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556096
12.
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.
Clin Cancer Res
; 30(8): 1630-1641, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319672
13.
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
EBioMedicine
; 102: 105048, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484556
14.
International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.
Cancer Immunol Immunother
; 67(11): 1809-1813, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182281
15.
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631161
16.
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
; 29(17): 3292-3300, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339186
17.
Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group.
Clin Genitourin Cancer
; 20(4): 388.e1-388.e10, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428584
18.
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Cancer Lett
; 529: 70-84, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971753
19.
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236742
20.
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577503